Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring
These results support the efficacy of the dapivirine vaginal ring for HIV-1 prevention and help to inform decision-making for women, providers, and policymakers regarding product use.
December 2023
Click for full info +Full Info:
Resource Type:
Journal Article
Journal Article
Resource
Citation:
Authors: Stalter, R.M., Dong, T.Q., Hendrix, C.W., Palanee-Phillips, T., van der Straten, A., Hillier, S.L., Kiweewa, F.M., Mgodi, N.M., Marzinke, M.A., Bekker, L.G., Soto-Torres, L., Baeten, J.M., Brown, E.R.
Health Risks(s):
- HIV
Product type(s):
- IVR
Topic(s):
- Development
- Risk
Region(s)
- Africa
- Global
Additional Keywords:
dapivirine, vaginal ring, preexposure prophylaxis, HIV-1, per sex act